‘No Foundation’ Seen For Guidant Criminal Inquiry
SG Cowen said it expects the medical device maker’s merger with J&J to go through at $76 per share.
From www.forbes.com/markets/2005/09/30/guidant-johnson-johnson-0930markets08.html?partner=rss ]]>”>Forbes Market Updates
